ONO PHARMACEUTICAL CO., LTD. Beat Consensus Estimates

ONO PHARMACEUTICAL CO., LTD. (OPHLF) reported earnings of $0.40 per share on revenue of $728.90 million for the fiscal first quarter ended June 2026. The consensus earnings estimate was $0.25 per share. The company beat consensus estimates by 60.00% while revenue fell 17.43% compared to the same quarter a year ago.

Ono Pharmaceuticals produces, purchases and sells pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals.